D25.1

Clinical Causes: Genetic factors that influence cell growth within the uterine muscle tissue Hormonal imbalances, particularly excess estrogen and progesterone, which promote the growth of fibroids Changes in reproductive hormones over time, especially during the reproductive years Age-related factors, with higher prevalence in women in their 30s and 40s Family history of uterine fibroids, suggesting a genetic predisposition Obesity, which can lead to increased estrogen levels Pregnancy, which temporarily increases hormone levels and may stimulate fibroid growth

Key Symptoms: Heavy menstrual bleeding (menorrhagia) Pelvic pressure or fullness Pain during menstruation or sexual intercourse Frequent urination due to pressure on the bladder Constipation caused by pressure on the rectum Lower back pain or pelvic discomfort Potentially asymptomatic, with fibroids found incidentally during examinations or imaging

Diagnosis Path: Diagnosis of an intramural leiomyoma typically involves a combination of clinical evaluation and imaging techniques. Healthcare providers may perform a pelvic exam to detect any enlargement or irregularities of the uterus. Confirmatory tests include ultrasound, particularly transvaginal ultrasound, which provides detailed images of uterine structures. In some cases, MRI may be utilized for precise assessment of fibroid size, location, and number. Additional testing might include hysterosonography or hysteroscopy if further evaluation of the uterine cavity is necessary. These diagnostic steps assist in differentiating fibroids from other uterine or pelvic conditions.

Treatment Protocols: Management options for intramural leiomyomas depend on factors such as size, location, symptoms, and the woman's reproductive plans. Common approaches include: - **Watchful waiting:** Monitoring fibroids that cause no symptoms or minimal discomfort. - **Medications:** Use of hormonal therapies like gonadotropin-releasing hormone (GnRH) agonists to reduce fibroid size temporarily, or medications controlling bleeding such as tranexamic acid or oral contraceptives. - **Minimally invasive procedures:** Uterine artery embolization to cut off blood supply, leading to fibroid shrinkage, or MRI-guided focused ultrasound. - **Surgical options:** Myomectomy (removal of fibroids while preserving the uterus) or hysterectomy (removal of the uterus) in more severe cases or when other treatments are ineffective. It is important to discuss the potential benefits and risks of each treatment with healthcare professionals, tailored to individual health needs and reproductive goals.